acceptodds
Under review as a conference paper at ICLR 2027

ExLLM: Efficient Experience-Enhanced LLMs for Large-Scale Discrete Optimization

Abstract

Large-scale discrete optimization involves vast, irregular search spaces where classical optimizers and learning-based methods struggle to incorporate expert knowledge and handle heterogeneous feedback under limited evaluation budgets. Recently, LLMs have been explored as optimizers, but existing approaches rely mainly on prompting or additional training, and lack mechanisms for scalable experience reuse. In particular, retrieval- or append-based memories accumulate redundancy, inflate prompts, and degrade exploration in long-horizon search. We introduce ExLLM (Experience-Enhanced LLM optimization), an LLM-as-optimizer framework designed for large discrete spaces. ExLLM integrates (i) a compact, evolving experience that distills non-redundant cues at low cost, (ii) a k-offspring sampling scheme that widens exploration per LLM call, and (iii) a lightweight feedback adapter that unifies objectives, constraints, and expert hints for iterative optimization. Starting from molecules, ExLLM achieves state-of-the-art performance on the PMO molecular optimization benchmark and generalizes strongly across domains, setting new records on circle packing and stellarator design, and delivering consistent gains on additional discrete and continuous optimization tasks. The framework transfers with only a task description and evaluation functions.

Primary area:
optimization
Keywords:
Discrete Optimization, Large Language Models, AI4Science, Evolutionary Algorithm

Reviews

Among:
Shape:
1234this paper, Top 49%
Figure 1. Mean review rating of the reviewed papers at ICLR 2027. This paper averages 2.33 over 3 reviews, above 51% of the others.
Reviewer_EBG4OpenReview ↗
Rating
3(+1)
Confidence
2
Informativeness
2
Presentation
2
Soundness
3
Read review
Paper summary

This paper introduces ExLLM, an LLM-as-optimizer, evolutionary algorithm for large-scale discrete optimization: An LLM generates kk offspring per call when given one parent pair, and optionally the experience distilled from all evaluated candidates so far, with probability PexpP_{exp}. At iteration tt, the next populations are selected from the complete candidate set based on a hybrid strategy: a half of candidates is decided based on the scalar fitness value, while the rest depends on the pareto optimality. Additionally, a feedback adapter normalizes objectives and formats constraints and expert hints for iteration.

ExLLM achieves strong results on the PMO benchmark (including single- and multi-objective optimization) when compared against strong baselines. It also generalizes to other domains.

Critical strengths

The empirical evaluation covers a broad set of baselines and tasks (both molecular design benchmark and problems from other domains), and ExLLM obtains strong results on most of the problems.

Critical weaknesses
  1. The diversity of the kk offspring generated in an LLM call is assumed, and kk is considered as a diversity-efficiency trade-off factor. However, from Figure 7, I see no clear pattern when varying kk: the ordering is not consistent across either backbones or tasks, and differences appear small. This might suggest that the diversity argument is weak, or different kk-s don’t really affect the results. Moreover, it might be more meaningful to report against the diversity metric rather than uniqueness, since the latter would still take non-duplicated but structurally similar molecules into account.
  2. It’s unclear how adapter works, and therefore how normalization is conducted. As a result, it’s also not clear to me how the history enters the experience: if the fitness score depends on the history, how stable or comparable the good / bad labels over iterations?
Questions for authors
  1. About the evolving experience: the evidence set is decided based on the fitness score only, while both fitness score and Pareto optimality are considered when selecting the next population. Is there a reason for using only the fitness score for the evidence set?
  2. Could you specify the normalization over objectives - is each objective normalized by a fixed, pre-defined range, or min/max computed from the context? If the latter, does the fitness score shift over time?
  3. Follow-up to 2: does the prompt for distilling experience receive numeric values, or only good/bad labels? If it’s the latter, the quantitive information would be discarded.
3 comments
AuthorsOpenReview ↗

Response to Reviewer EBG4

We thank the reviewer for recognizing the breadth of the evaluation and the optimization results. We clarify the evidence for k-offspring generation, experience-set selection, and numerical feedback below.


The diversity of the k offspring generated in an LLM call is assumed. Figure 7 shows no clear ordering as k varies, and uniqueness does not necessarily measure structural diversity.

Response:

The k-offspring ablation in Section 7.2.1 examines a trade-off rather than a monotonic improvement with k. Moving from k = 1 to k = 2 improves GPT-4o's Top-10 AUC from 0.644 ± 0.025 to 0.698 ± 0.038 on JNK3, and from 3.975 ± 0.088 to 4.015 ± 0.074 on the five-objective task. With Gemini-2.5-Flash, uniqueness also increases from 0.376 to 0.686 on JNK3 and from 0.300 to 0.390 on the five-objective task. Larger k gives less consistent gains and sometimes reduces performance.

Autoregressive generation allows later candidates to condition on earlier candidates within the same response, providing an opportunity to vary proposals. Although this does not guarantee structural diversity, our ablations support its benefits for exploration and final solution quality. Because generating multiple candidates also shares the input prompt across them, reducing repeated input tokens and LLM calls, which can lower API cost and running time.

As complementary evidence, with the same GPT-4o backbone, ExLLM without evolving experience achieves Top-10 fitness of 4.245 ± 0.121, compared with 4.076 ± 0.020 for MOLLEO on the five-objective task, and 18.165 versus 17.862 on PMO. The direct k ablation above isolates the effect of k; the MOLLEO comparison supports the effectiveness of the remaining k-offspring design.


The experience evidence set appears to use only fitness, whereas population selection uses both fitness and Pareto optimality. Is there a reason for using only the fitness score for the evidence set?

Response:

Thank you for your question, we would like to clarifty that the implementation considers both fitness and Pareto optimality when selecting positive examples for the experience update. It samples 10 positive examples uniformly from either the fitness-based pool or the Pareto-based pool, choosing each pool with probability 0.5, as implemented in algorithm/PromptTemplate.py. Both population selection and experience samples selection therefore use fitness and Pareto information. The current description of the positive examples as only “top-r by fitness” is incomplete, and we will correct it in the method section.


Is each objective normalized using a fixed, predefined range or min/max values computed from the search history? Does fitness shift over time?

Response:

Each objective uses a fixed, predefined normalization range or scale, following the task definition and known objective ranges. For molecular optimization, we follow MOLLEO's normalization. We do not compute min/max values from the current population or search history, so the same objective values always receive the same fitness throughout a run. The good/bad examples therefore remain comparable across generations.


Does the experience-generation prompt receive numerical values or only good/bad labels? If only labels are provided, quantitative information would be discarded.

Response:

The experience-generation prompt receives numerical values. Each selected candidate is included with its representation(such as SMILES in the molecular experiments), its raw value for each objective, and its aggregate fitness. When constraint feedback is available, the candidate's constraint values or diagnostic feedback are included as well. The experience update therefore has access to both the candidate and its quantitative evaluation.

The prompt then asks the LLM to summarize actionable patterns and pitfalls in a single evolving experience of approximately 200 words, integrating the previous experience and removing redundant or outdated content. Thus, numerical evidence is preserved in the experience-generation input, while the output deliberately compresses it into reusable guidance rather than repeating each candidate and its scores. We will clarify this distinction in the method section.

Thank you for the clarifications. While the k-offspring ablation does not offer a consistent practical guideline for selecting k, I find the overall approach sound and the reported performance promising. Given the agreed revisions to the manuscript:

  • clarifying how positive examples are selected for the experience update,
  • clarifying how objectives are normalized across populations, and
  • clarifying how the experience-generation prompt is constructed

I am happy to raise my score to weak accept.

Thank you so much for your positive assessment and constructive feedback. We greatly appreciate your recognition of the overall soundness and promising performance of ExLLM. We will incorporate the three agreed clarifications into the revised manuscript.

Reviewer_nAGoOpenReview ↗
Rating
2
Confidence
3
Informativeness
2
Presentation
2
Soundness
2
Read review
Paper summary

The paper proposes ExLLM, an LLM-based evolutionary framework for discrete optimization problems. This method combines an updated summary of past search experience, multiple candidate generations per call, and selection based on both fitness and Pareto dominance. Experiments on molecular optimization and several other tasks show competitive solution quality with reduced LLM query costs.

Critical strengths
  1. The framework provides improvements under reduced budgets. The k-offspring mechanism and the corresponding ablation studies offer meaningful insights into the tradeoff between exploration and generation cost. Also, the comparison with MOLLEO using the same GPT-4o gives evidence of better optimization quality and lower API cost.

  2. The experiments cover a broad range of tasks across multiple scientific and engineering domains. These selected tasks are relevant to useful scientific discovery and engineering optimization.

Critical weaknesses

My main concerns are two points described below:

  1. The timeliness and the relevance of this work. The work itself is interesting; however, as general-purpose agents get stronger and stronger, it's more natural to deal with these scientific discovery and engineering tasks with agents equipped with tools, feedback, and memory. Many mechanisms proposed by this paper, like iterative candidate generation, experience management and feedback-driven refinement, are already supported by current agent systems.

  2. The design of the framework feels ad-hoc and tailored to molecular optimization. The proposed ExLLM framework is largely motivated by molecular tasks. Though the paper includes cross-domain experiments, it seems that applying the framework elsewhere still needs additional design, such as SLSQP refinement for circle packing, solver integration for routing, and curated SDK knowledge for kernel optimization)

Besides these, the organization of the paper could also be improved. The core method section introduces several mechanisms before explaining them clearly, which is not very friendly for first-time readers. There are also missing spaces in several places, like line 161 "key components.We" and line 303 "populations (size 100 each):Best-init:" "bottom-100;Random-init:".

Questions for authors
  1. How does ExLLM compare with strong general-purpose agents? Could the authors provide a comparison under comparable budgets to clarify the ExLLM's practical advantage over current agent systems?

  2. When applying ExLLM beyond molecular optimization, which components can be reused without any change? And how much additional engineering and domain knowledge are needed to apply the framework to a new task?

4 comments
AuthorsOpenReview ↗

Response to Reviewer nAGo

We thank the reviewer for recognizing the improvements in optimization quality and efficiency, and the relevance of the cross-domain applications. We address your questions below.


The timeliness and relevance of this work: How does ExLLM compare with strong general-purpose agents under comparable budgets?

Response:

We found a recent independent study in which five Codex agents using GPT-6 Astra autonomously developed a molecular optimizer. Both methods are evaluated on all 23 PMO tasks with 10,000 oracle evaluations per task and run. ExLLM achieves an aggregate Top-10 AUC of 19.165, compared with 17.387, demonstrating higher optimization quality under the same oracle-evaluation budget. We also summarize selected recent molecular optimization methods below. These are results reported in the respective publications. ExLLM achieves a higher aggregate score than these selected methods, including the optimizer developed by general-purpose agents.

MethodMethod typePMO Top-10 AUCPublication
ExLLMLLM-based evolutionary optimization19.165This work
Five-agent Codex by GPT-6 Astra [1]Agent-developed optimizer17.387bioRxiv, October 2026
InVirtuoGen [2]Generative model16.676ICLR 2026
GenMol [3]Discrete diffusion18.362ICML 2025

Overall, ExLLM provides an empirically validated, efficient framework for long-horizon optimization across multiple domains. Its k-offspring strategy and compact evolving experience support effective search over extended optimization runs, achieving state-of-the-art results with faster speed and lower API cost compared to MOLLEO and several control memory mechanisms in Table 1, Table 18 and Table 19. Reference:

[1] Smbatyan et al. Evaluating Autonomous LLM Agents Across Molecular Prediction and Optimization Benchmarks. bioRxiv 2026.
[2] Kaech et al. Refine Drugs, Don't Complete Them: Uniform-Source Discrete Flows for Fragment-Based Drug Discovery. ICLR 2026.
[3 ] Lee et al. GenMol: A Drug Discovery Generalist with Discrete Diffusion. ICML 2025.


The framework feels ad hoc and tailored to molecular optimization. Beyond molecular optimization, which components can be reused without any change, and how much additional engineering and domain knowledge are needed?

Response:

Minimizing additional engineering and domain knowledge was a design goal of ExLLM. Across the six application areas beyond molecular optimization: peptide design, circle packing, stellarator design, MOTSP/MOCVRP, offshore platform jacket optimization, and kernel optimization, we apply the same ExLLM algorithm with the same hyperparameters. Each application supplies a brief description of the task and objectives, an output format, and its evaluator. For circle packing, proposals are refined using a fixed SLSQP solver, following the same proposal-and-refinement procedure as AlphaEvolve[5]. For kernel optimization, debugger/compiler messages are returned in each candidate's constraint information. These are standard procedures and complete feedback integration and we have provided example files under problem/ directory.

Thus, applying ExLLM requires a basic problem description and evaluator code, organized through prompt_info.yaml, config.yaml, and evaluator.py in the problem/ directory. Task-specific crossover and mutation instructions are optional and can leave empty; the hyperparameters are reused across all applications.

[4] Alexander et.al. AlphaEvolve: A coding agent for scientific and algorithmic discovery. DeepMind, 2025


The core method introduces several mechanisms before explaining them clearly, and several places have missing spaces.

Response:

Thank you for identifying these presentation issues. We will revise the opening of the method section to explain one complete generation in order: parent selection, k-offspring generation, evaluation and feedback, hybrid selection, and experience update. We will define the experience and feedback interface when they first appear, before introducing their detailed mechanisms. This clarification can be made within the existing organization. We will also correct the missing spaces, including “key components.We” and the initialization labels “Best-init,” “Worst-init,” and “Random-init,” and check the manuscript for similar formatting issues.

Thank you for the detailed response and the additional experiments. I appreciate the authors’ efforts to address my comments. However, the cross-paper comparisons still leave me uncertain about ExLLM’s practical advantage over current general-purpose agents. I also remain concerned about the task-specific engineering and domain knowledge needed for new applications, even with the same core algorithm. While I find the direction interesting, these concerns remain, so I will keep my original rating of weak rejection.

AuthorsOpenReview ↗

Additional response to Reviewer nAGo addressing strong-purpose agent results and transferring details

The cross-paper comparisons still leave me uncertain about ExLLM’s practical advantage over current general-purpose agents.

Response:

To address this concern directly, we additionally ran Codex (GPT-6.1 Sol, high) and Cursor (Grok 4.7, high) on the five-objective molecular optimization task. Both agents received the task description, evaluator, metric definitions, and the five random initial populations that are exactly the same initial population of ExLLM runs, with same 5,000 evaluation budget**. They could freely choose their search strategies, execute code, use tools and online search, and maintain workspace notes; accessing existing experimental results that may cause data leakage was prohibited. No ExLLM search strategy was prescribed.

Both agents autonomously implemented molecular search procedures combining graph edits/crossover and surrogate-based candidate selection. The results below are mean ± standard deviation across five seeds.

Agent / optimizerTop-10 F ↑Top-10 AUC ↑HV ↑Uniqueness ↑Validity ↑Diversity ↑
Codex (GPT-6.1 Sol, high)4.081 ± 0.1263.945 ± 0.0530.811 ± 0.1600.671 ± 0.0250.881 ± 0.0070.524 ± 0.140
Cursor (Grok 4.7, high)4.174 ± 0.1504.062 ± 0.1100.870 ± 0.2500.505 ± 0.0470.994 ± 0.0060.467 ± 0.082
ExLLM (GPT-4o)4.300 ± 0.1644.116 ± 0.0400.905 ± 0.2000.872 ± 0.0150.908 ± 0.0190.533 ± 0.041

ExLLM still obtains higher mean final Top-10 fitness, HV and Top-10 AUC than both agents under the same oracle-evaluation budget. These direct runs provide additional evidence for the practical value of ExLLM's optimization mechanisms alongside current general-purpose agents. This comparison supports an optimization-quality advantage.


I also remain concerned about the task-specific engineering and domain knowledge needed for new applications, even with the same core algorithm.

Response:

In addition to the cross-domain evidence provided above, we would like to clarify the task-specific work required to apply ExLLM: connecting the evaluation environment and supplying its problem specification and available feedback. This means providing a brief description of the task and objectives, the candidate/output format, and evaluator code that returns objective values and any available constraint or diagnostic feedback. These are basic inputs needed to define and evaluate an optimization task; they do not require users to prescribe a search strategy or provide detailed domain-specific optimization rules. ExLLM then uses the same optimization mechanisms and shared hyperparameters. We will make these interface requirements explicit in the revised manuscript. The detailed examples can be inspected in our open-source code under "problem/" directory, showing the simplicity of transferring.

We hope this can address you concerns, thank you very much for your comments.

Dear Reviewer nAGo, we have provided concise additional responses addressing your concerns directly. We would greatly appreciate it if you could take a moment to review them. Thank you for your time and thoughtful comments.

Reviewer_YyaMOpenReview ↗
Rating
2
Confidence
4
Informativeness
1
Presentation
2
Soundness
2
Read review
Paper summary

This paper uses an LLM as the optimizer for molecular design and several other discrete problems. Each generation selects parent pairs, prompts the model for a few offspring, evaluates them with the task oracle, and keeps a short experience memo that the same model rewrites from the best and worst candidates so far. A feedback adapter normalizes objectives, formats constraints and expert hints, and promotes a binding constraint into an objective, and selection mixes fitness ranking with a Pareto front. The method is evaluated on PMO, on a five-objective task under three initial populations, and on cross-domain demonstrations, and reports the highest PMO aggregate score among the compared methods.

Critical strengths

The method is specified closely enough to be reimplemented. The prompt template, the default configuration and the selection rule are given, and an anonymized repository covers the rest.

The evaluation is broad within the molecular setting. It covers the full PMO suite, three initialization regimes, component ablations, and cost and wall-clock accounting against a same-LLM baseline.

Critical weaknesses

The claimed scope is wider than measured. The title promises a general optimizer for large-scale discrete optimization, while the evidence is a molecular study with demonstrations elsewhere. Some of those domains add their own integration work, such as a local solver after the proposals or a feasibility term in the objectives. The abstract claim that it transfers with only a task description and evaluation functions reads stronger than that.

The memory is undersupported as described. Section 3.1 says the memo captures frequently binding constraints, reusable edit patterns and common invalid cases. The entries in the appendix are generic medicinal chemistry advice, with no measured values, named constraints or candidate-level evidence. Whether the gain comes from distilled search evidence or from priors the model supplies anyway is therefore open.

Questions for authors
  1. What values of the top-r cut-off, the bad-sample set and the memo length are used?
  2. Could the authors show one memo entry that records a measured value from an evaluated candidate?
  3. How would they separate that evidence from priors the model produces even with no evaluated candidates?
  4. Which oracle budget is used for the full PMO comparison, and are discarded invalid SMILES counted against it?
  5. Table 1 and the appendix table report different hypervolumes for the same task. Are the configurations identical, as the captions state?
  6. The celecoxib row reports the same mean and standard deviation in two columns. Was one entry copied by mistake?
5 comments
AuthorsOpenReview ↗

Response to Reviewer YyaM [1/2]

We thank the reviewer for the careful assessment. We address each question below.


What values of the top-r cut-off, the bad-sample set and the memo length are used?

Response:

The experience update uses 10 positive examples and 10 relatively bad examples, together with the previous memo. The postive examples are selected by fitness or pareto optimality with equal probability (0.5 each). The bad-example is to sample 10 candidates randomly from the lower-fitness half of the historical archive. The summarization prompt requests a single memo within 200 words. The update merges new evidence with the previous memo and asks the model to remove redundant or outdated advice. Updates are performed once per generation. we will clarify these details in method section.


Could the authors show one memo entry that records a measured value from an evaluated candidate?

Response:

The experience-generation prompt explicitly includes the good examples and bad samples described above, together with each candidate's SMILES, individual numerical objective values, and aggregate fitness. The LLM therefore has access to the concrete evaluated structures and quantitative feedback when generating the experience; it does not receive only good/bad labels or a general task description.

Our instruction then asks the LLM to compress this information into a short memo of approximately 200 words, focusing on actionable structural patterns, useful editing strategies, and pitfalls to avoid, rather than repeating the SMILES and scores of every molecule. The instruction explicitly requests: “Keep the summary concise (within 200 words), focusing on actionable insights and avoiding redundancy. Don't describe the given candidates, directly state the experience.” This distinction between detailed numerical evidence in the input and compact guidance in the output is intentional and contributes to the efficiency of our experience design. Consequently, the memo is a summary conditioned on evaluated candidates, rather than a candidate-by-candidate measurement record.

The effectiveness of this design is supported by the experience-injection ablation in Section 7.2.2 and the PMO comparison with and without experience. In the former, using the default experience-injection probability of 0.5 improves Top-10 AUC from 4.015 ± 0.074 to 4.116 ± 0.040, and hypervolume from 0.850 ± 0.224 to 0.905 ± 0.200, relative to no experience. On PMO, evolving experience increases the aggregate score from 18.165 to 19.165, an improvement of 1.000 point. We will clarify that the numerical candidate evidence is supplied during distillation, whereas the resulting memo intentionally retains compact, reusable guidance.

AuthorsOpenReview ↗

Response to Reviewer YyaM [2/2]

The memory is undersupported as described. Section 3.1 says the memo captures frequently binding constraints, reusable edit patterns and common invalid cases. The entries in the appendix are generic medicinal chemistry advice, with no measured values, named constraints or candidate-level evidence.

How would they separate that evidence from priors the model produces even with no evaluated candidates?

Response:

We would like to draw attention to the paired initial and final experiences for both five-objective optimization and JNK3 optimization in Section 7.8. These pairs are included to illustrate how the experience changes during search:

  • Five-objective optimization: The initial experience discusses broad properties such as balanced substituents, aromatic/heterocyclic systems, and controlled molecular complexity. The final experience identifies benzene and thiophene cores, amides, carbamates, esters, and ethers, and specifically emphasizes aromatic monosubstitution and linear, compact structures when balancing SA, QED, DRD2, GSK3β, and JNK3. Thus, the advice develops from general structural considerations into more particular choices of scaffolds, functional groups, and substitution patterns.
  • JNK3 optimization: The initial experience lists broad motifs such as aromatic rings, heterocycles, amines, ethers, and sulfoxides. The final experience places emphasis on sulfonamide/sulfonyl moieties, functionalized N-substituents, and flexible or cyclic linkers, together with avoiding steric hindrance and ineffective ring substitutions. These are concrete candidate-design actions rather than simply restating the instruction to increase JNK3.

We do a case study of the trajectory, an experience-guided query proposed replacing a chloro substituent with fluoro while retaining the aryl/heteroaryl scaffold, nitrile, methoxy, and amide groups. The query included the saved experience emphasizing these substituents together with both evaluated parents and their numerical objective values. The resulting child increased JNK3 from 0.43 to 0.53 relative to the structurally closest parent and increased aggregate fitness from 4.0486 to 4.1317, exceeding the other parent’s fitness of 4.1001.

The initial experience is an summary after the first generation, before extensive experience has accumulated, whereas the final experience results from repeatedly integrating newly evaluated good/bad candidates with the previous memo. As explained above, each update receives candidate SMILES, numerical objective values, and fitness. The output deliberately compresses that information into reusable patterns and pitfalls within approximately 200 words, instead of repeating every candidate and its measurements. The absence of a numerical candidate ledger in the displayed memo therefore reflects the compression objective, rather than an absence of quantitative evidence in the distillation input. The no-experience ablation also shows that adding evolving experience improves Top-10 AUC and hypervolume in Section 7.2.2, and raises the PMO aggregate score from 18.165 to 19.165. These results show the practical benefit of maintaining and reusing the evolving summary beyond the same model's prior knowledge.


Which oracle budget is used for the full PMO comparison, and are discarded invalid SMILES counted against it?

Response:

The full PMO comparison uses the standard 10k oracle-evaluation budget, same as the setting in PMO paper. Invalid SMILES are rejected before calling the property oracle and do not consume the oracle budget, but invalid and duplicate proposals can still consume LLM tokens and wall-clock time.


Table 1 and the appendix table report different hypervolumes for the same task. Are the configurations identical, as the captions state?

The celecoxib row reports the same mean and standard deviation in two columns. Was one entry copied by mistake?

Response:
Yes, Table 1 and the random-initialization setting of Table 2 use the same experimental configuration. The discrepancy arose because the results of ExLLM was not updated in Table 1, we will revise HV, top 10 AUC of ExLLM in Table 1. The Genetic-GFN celecoxib-rediscovery entry is a separate copy-and-paste error: it should be 0.802 ± 0.024, rather than 0.891 ± 0.033. With this corrected entry, the 23 Genetic-GFN task values sum to 16.213, exactly matching the reported aggregate total. These corrections do not change the aggregate totals, overall rankings, main conclusions, or significance of the reported findings. We thank the reviewer for identifying these reporting inconsistencies.

Thank you for the detailed response. While it clarifies several experimental settings and acknowledges the reporting errors, it does not resolve my concerns about whether the experience memory adds value beyond the model’s prior knowledge or whether the evidence supports the paper’s claims of generality. I therefore maintain my original rating of 2.

Comments on the paper

1 comment

Dear Reviewer YyaM, nAGo,

Thank you for your valuable feedback! We have addressed your comments and streamlined our rebuttal to make the responses easier to follow.

We would greatly appreciate it if you could take a moment to review our responses and share any further thoughts before the discussion deadline.

From OpenReview, CC BY 4.0. Authors as signed there; shown unedited.

Related papers

Loading the map…

Discussion (0)

Sign in to comment.